Daily Mail [UK], by Jenny Hope Posted By: Attercliffe- Thu, 02 Feb 2012 04:57:52 GMT A ?breakthrough? drug that gives extra months of life to men with advanced prostate cancer has been rejected for use on the NHS. The once'daily pill was developed by UK scientists at the Institute of Cancer Research (ICR) and trials were partly funded by British charities. But it has been branded as too expensive by the rationing watchdog the National Institute for Health and Clinical Excellence. Abiraterone is the latest prostate cancer drug to face an NHS ban despite being proven to extend life for men with advanced disease. Last month another drug''Jevtana''was turned down as ?not cost'effective?.
Tags: Breaking News, Current Events, Lucianne
This entry was posted on Thursday, February 2nd, 2012 at 4:57 am and is filed under Lucianne.com. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.
Comments are closed.
Source: http://www.newmediablog.com/2012/02/now-patients-are-denied-breakthrough-prostate-cancer-drug-as-health-watchdogs-brand-it-too-expensive/
addams family in time
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.